Integrated Risk Assessment Coupled with Molecular Detection Platform Enhance Personalized Health Care in Metabolic Disorders

Type 2 diabetes mellitus (T2DM) is characterised by multidimensional metabolic dysfunction caused by endothelium and beta cell malfunction, as well as regulatory molecular dysfunction caused by stress, lifestyle, food, and physical inactivity anchored in the insulin signalling network. It is

Read More